Search Results - "D'SILVA, KRISTIN"

Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases by Cook, Claire, Patel, Naomi J, D'Silva, Kristin M, Hsu, Tiffany Y-T, DiIorio, Michael, Prisco, Lauren, Martin, Lily W, Vanni, Kathleen, Zaccardelli, Alessandra, Todd, Derrick, Sparks, Jeffrey A, Wallace, Zachary Scott

Get more information

Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry by Gianfrancesco, Milena A., Leykina, Liza A., Izadi, Zara, Taylor, Tiffany, Sparks, Jeffrey A., Harrison, Carly, Trupin, Laura, Rush, Stephanie, Schmajuk, Gabriela, Katz, Patricia, Jacobsohn, Lindsay, Hsu, Tiffany Y., D’Silva, Kristin M., Serling‐Boyd, Naomi, Wallwork, Rachel, Todd, Derrick J., Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Hausmann, Jonathan S., Liew, Jean W., Sirotich, Emily, Sufka, Paul, Wallace, Zachary S., Machado, Pedro M., Robinson, Philip C., Yazdany, Jinoos

“…Objective Racial/ethnic minorities experience more severe outcomes of coronavirus disease 2019 (COVID‐19) in the general US population. This study was…”
Get full text

Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis by D'Silva, Kristin M., Mehta, Raaj, Mitchell, Michael, Lee, Todd C., Singhal, Vibha, Wilson, Marnie Goodwin, McDonald, Emily G.

“…Proton pump inhibitor (PPI) therapy is a potentially modifiable risk factor for recurrent Clostridioides difficile infection (CDI). Citing an absence of…”
Get full text

A Rapid Change in Pressure by D’Silva, Kristin, Cockrill, Barbara, Anderson, William J, Miller, Amy L, Loscalzo, Joseph

“…A 74-year-old woman presented with a 6-week history of progressive dyspnea on exertion. She also noted a nonproductive cough, fatigue, loss of appetite, and an…”
Get full text

Gasping for a Diagnosis by D’Silva, Kristin, Brown, Sarah, Hunninghake, Gary M, Vivero, Marina, Loscalzo, Joseph

“…A 42-year-old man presented with progressive nonproductive cough, shortness of breath, and unintentional weight loss. He reported no fevers, chills, night…”
Get full text

Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series by Dobre, Ioana A., Frank, Angela J., D'Silva, Kristin M., Christiani, David C., Okin, Daniel, Sharma, Amita, Montesi, Sydney B.

“…Immune checkpoint inhibitors (ICIs), such as programmed cell death 1 (PD-1) inhibitors, are used to treat multiple cancers. Limited data exist as to the use of…”
Get full text

A Rapid Change in Pressure by D’Silva, Kristin, Vaidya, Anand, Smithy, James W, Anderson, William J, Cockrill, Barbara

“…This interactive feature describes a patient who presents with progressive dyspnea on exertion, a nonproductive cough, fatigue, and unintentional weight loss…”
Get full text

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study by Di Iorio, Michael, Cook, Claire E., Vanni, Kathleen M.M., Patel, Naomi J., D'Silva, Kristin M., Fu, Xiaoqing, Wang, Jiaqi, Prisco, Lauren C., Kowalski, Emily, Zaccardelli, Alessandra, Martin, Lily W., Qian, Grace, Hsu, Tiffany Y-T., Wallace, Zachary S., Sparks, Jeffrey A.

“…To describe disease-modifying antirheumatic drug (DMARD) disruption, rheumatic disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19…”
Get full text

Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial by Merrill, Joan T., Tanaka, Yoshiya, D'Cruz, David, Vila‐Rivera, Karina, Siri, Daniel, Zeng, Xiaofeng, Saxena, Amit, Aringer, Martin, D'Silva, Kristin M., Cheng, Ling, Mohamed, Mohamed‐Eslam F., Siovitz, Lucia, Bhatnagar, Sumit, Gaudreau, Marie‐Claude, Doan, Thao T., Friedman, Alan

“…Objective The 48‐week, phase 2 SLEek study (NCT03978520) evaluated the efficacy and safety of upadacitinib (JAK inhibitor) and elsubrutinib (BTK inhibitor)…”
Get full text

Assessing the Severity of COVID‐19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning–Derived Chest Radiograph Scores by Patel, Naomi J., D'Silva, Kristin M., Li, Matthew D., Hsu, Tiffany Y. T., DiIorio, Michael, Fu, Xiaoqing, Cook, Claire, Prisco, Lauren, Martin, Lily, Vanni, Kathleen M. M., Zaccardelli, Alessandra, Zhang, Yuqing, Kalpathy‐Cramer, Jayashree, Sparks, Jeffrey A., Wallace, Zachary S.

“…Objective COVID‐19 patients with rheumatic disease have a higher risk of mechanical ventilation than the general population. The present study was undertaken…”
Get full text

Mortality trends in polymyositis and dermatomyositis: A general population-based study by Li, Lingyi, D'Silva, Kristin M., Lu, Na, Huang, Kun, Esdaile, John M., Choi, Hyon K., Aviña-Zubieta, J. Antonio

“…•Polymyositis (PM) and dermatomyositis (DM) are rare autoimmune inflammatory myopathies associated with significant premature mortality.•However, it is unclear…”
Get full text

Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance by Ugarte‐Gil, Manuel F., Alarcón, Graciela S., Seet, Andrea M., Izadi, Zara, Montgomery, Anna D., Duarte‐García, Alí, Gilbert, Emily L., Valenzuela‐Almada, Maria O., Wise, Leanna, Sparks, Jeffrey A., Hsu, Tiffany Y.‐T., D'Silva, Kristin M., Patel, Naomi J., Sirotich, Emily, Liew, Jean W., Hausmann, Jonathan S., Sufka, Paul, Grainger, Rebecca, Bhana, Suleman, Wallace, Zachary, Jacobsohn, Lindsay, Strangfeld, Anja, Mateus, Elsa F., Hyrich, Kimme L., Gossec, Laure, Carmona, Loreto, Lawson‐Tovey, Saskia, Kearsley‐Fleet, Lianne, Schaefer, Martin, Machado, Pedro M., Robinson, Philip C., Gianfrancesco, Milena, Yazdany, Jinoos

“…Objective To determine the association between race/ethnicity and COVID‐19 outcomes in individuals with systemic lupus erythematosus (SLE). Methods Individuals…”
Get full text

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 by Stone, John H, Frigault, Matthew J, Serling-Boyd, Naomi J, Fernandes, Ana D, Harvey, Liam, Foulkes, Andrea S, Horick, Nora K, Healy, Brian C, Shah, Ruta, Bensaci, Ana Maria, Woolley, Ann E, Nikiforow, Sarah, Lin, Nina, Sagar, Manish, Schrager, Harry, Huckins, David S, Axelrod, Matthew, Pincus, Michael D, Fleisher, Jorge, Sacks, Chana A, Dougan, Michael, North, Crystal M, Halvorsen, Yuan-Di, Thurber, Tara K, Dagher, Zeina, Scherer, Allison, Wallwork, Rachel S, Kim, Arthur Y, Schoenfeld, Sara, Sen, Pritha, Neilan, Tomas G, Perugino, Cory A, Unizony, Sebastian H, Collier, Deborah S, Matza, Mark A, Yinh, Janeth M, Bowman, Kathryn A, Meyerowitz, Eric, Zafar, Amna, Drobni, Zsofia D, Bolster, Marcy B, Kohler, Minna, D’Silva, Kristin M, Dau, Jonathan, Lockwood, Megan M, Cubbison, Caroline, Weber, Brittany N, Mansour, Michael K

“…The efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for…”
Get full text

COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study by D’Silva, Kristin M., Jorge, April, Cohen, Andrew, McCormick, Natalie, Zhang, Yuqing, Wallace, Zachary S., Choi, Hyon K.

“…Objective Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be concerned about risks of severe coronavirus disease 2019 (COVID‐19)…”
Get full text

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot' by D'Silva, Kristin M, Serling-Boyd, Naomi, Wallwork, Rachel, Hsu, Tiffany, Fu, Xiaoqing, Gravallese, Ellen M, Choi, Hyon K, Sparks, Jeffrey A, Wallace, Zachary S

“…To investigate differences in manifestations and outcomes of coronavirus disease 2019 (COVID-19) infection between those with and without rheumatic disease. We…”
Get more information

Upadacitinib in Active Non‐radiographic Axial Spondyloarthritis: 1‐Year Data From a Double‐Blind, Randomized, Placebo‐Controlled, Phase 3 Trial by Van den Bosch, Filip, Deodhar, Atul, Poddubnyy, Denis, Maksymowych, Walter P., Heijde, Désirée, Kim, Tae‐Hwan, Kishimoto, Mitsumasa, Baraliakos, Xenofon, Li, Yihan, D'Silva, Kristin, Wung, Peter, Song, In‐Ho

“…Objective Upadacitinib improved the signs and symptoms of non‐radiographic axial spondyloarthritis (nr‐axSpA) versus placebo over 14 weeks in the primary…”
Get full text

Transient blindness with periorbital erythema and swelling: Manifestations of recurrent systemic lupus erythematosus by Hafeez, Farhaan, Gunasekera, Nicole S., D'Silva, Kristin M., Nazarian, Rosalynn M.

Get full text

COVID-19 and rheumatoid arthritis by D'Silva, Kristin M., Wallace, Zachary S.

“…The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality worldwide. Patients with rheumatoid arthritis (RA) face unique…”
Get full text

Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic by Serling-Boyd, Naomi, D'Silva, Kristin M, Hsu, Tiffany Yt, Wallwork, Rachel, Fu, Xiaoqing, Gravallese, Ellen M, Jorge, April M, Zhang, Yuqing, Choi, Hyon, Sparks, Jeffrey A, Wallace, Zachary S

“…In earlier studies, patients with rheumatic and musculoskeletal disease (RMD) who got infected with COVID-19 had a higher risk of mechanical ventilation than…”
Get more information

SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease by D'Silva, Kristin M, Serling-Boyd, Naomi, Hsu, Tiffany Y-T, Sparks, Jeffrey A, Wallace, Zachary S

Get more information